PureTech Health shares jump 13% after $500 million sale of royalties for schizophrenia drug
- Shares jump 13% after selling royalties for up to $500m- Positive late-stage trial results from schizophrenia drug- Company retains 3.1% stake in Karuna worth $180mShares in FTSE 250 biotherapeutics company PureTech Health (PRTC)...
23 March 2023